nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC6A2—autonomic nervous system—conduct disorder	0.0181	0.314	CbGeAlD
Norepinephrine—Methyldopa—COMT—conduct disorder	0.0168	0.271	CrCbGaD
Norepinephrine—Phenylephrine—MAOA—conduct disorder	0.013	0.21	CrCbGaD
Norepinephrine—SLC18A1—brain—conduct disorder	0.009	0.156	CbGeAlD
Norepinephrine—Dopamine—COMT—conduct disorder	0.00822	0.132	CrCbGaD
Norepinephrine—L-DOPA—DRD4—conduct disorder	0.00716	0.115	CrCbGaD
Norepinephrine—Dopamine—DRD4—conduct disorder	0.00666	0.107	CrCbGaD
Norepinephrine—PAH—brain—conduct disorder	0.00646	0.112	CbGeAlD
Norepinephrine—Dopamine—MAOA—conduct disorder	0.0062	0.0998	CrCbGaD
Norepinephrine—Dopamine—SLC6A4—conduct disorder	0.004	0.0644	CrCbGaD
Norepinephrine—ADRA1B—brain—conduct disorder	0.0029	0.0503	CbGeAlD
Norepinephrine—SLC18A2—brain—conduct disorder	0.00288	0.0498	CbGeAlD
Norepinephrine—ADRA1D—brain—conduct disorder	0.00284	0.0492	CbGeAlD
Norepinephrine—SLC22A1—brain—conduct disorder	0.00214	0.0371	CbGeAlD
Norepinephrine—ADRB1—brain—conduct disorder	0.00206	0.0357	CbGeAlD
Norepinephrine—SLC22A3—brain—conduct disorder	0.00205	0.0355	CbGeAlD
Norepinephrine—PAH—Metabolism—CGA—conduct disorder	0.00198	0.00224	CbGpPWpGaD
Norepinephrine—SLC18A2—Neuronal System—COMT—conduct disorder	0.00189	0.00214	CbGpPWpGaD
Norepinephrine—SLC18A2—Neuronal System—MAOA—conduct disorder	0.00187	0.00213	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00182	0.00207	CbGpPWpGaD
Norepinephrine—SLC22A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00182	0.00207	CbGpPWpGaD
Norepinephrine—SLC22A5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00182	0.00206	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—CGA—conduct disorder	0.00182	0.00206	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00176	0.002	CbGpPWpGaD
Norepinephrine—SLC6A2—brain—conduct disorder	0.00175	0.0304	CbGeAlD
Norepinephrine—ADRB1—GPCR ligand binding—CGA—conduct disorder	0.00165	0.00188	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.00164	0.00186	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00163	0.00186	CbGpPWpGaD
Norepinephrine—ADRA1A—brain—conduct disorder	0.00163	0.0283	CbGeAlD
Norepinephrine—ADRB2—GPCR ligand binding—CGA—conduct disorder	0.00162	0.00184	CbGpPWpGaD
Norepinephrine—DRD2—brain—conduct disorder	0.0016	0.0277	CbGeAlD
Norepinephrine—ADRB3—GPCR downstream signaling—CGA—conduct disorder	0.00158	0.00179	CbGpPWpGaD
Norepinephrine—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00156	0.00177	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR ligand binding—DRD4—conduct disorder	0.00156	0.00177	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00156	0.00177	CbGpPWpGaD
Norepinephrine—ADRA2C—brain—conduct disorder	0.00155	0.0269	CbGeAlD
Norepinephrine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00155	0.00176	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—CGA—conduct disorder	0.00153	0.00174	CbGpPWpGaD
Norepinephrine—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.00152	0.00172	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.00151	0.00171	CbGpPWpGaD
Norepinephrine—SLC22A5—brain—conduct disorder	0.00149	0.0258	CbGeAlD
Norepinephrine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.00146	0.00165	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—CGA—conduct disorder	0.00143	0.00163	CbGpPWpGaD
Norepinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00142	0.00161	CbGpPWpGaD
Norepinephrine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00142	0.00161	CbGpPWpGaD
Norepinephrine—ADRA2C—G alpha (i) signalling events—DRD4—conduct disorder	0.00142	0.00161	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00141	0.0016	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.00139	0.00158	CbGpPWpGaD
Norepinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00139	0.00158	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00134	0.00152	CbGpPWpGaD
Norepinephrine—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00134	0.00152	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00134	0.00152	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00134	0.00152	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00133	0.00151	CbGpPWpGaD
Norepinephrine—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.00132	0.00149	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00131	0.00149	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00129	0.00147	CbGpPWpGaD
Norepinephrine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.00129	0.00146	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00124	0.00141	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00124	0.00141	CbGpPWpGaD
Norepinephrine—ADRA2A—brain—conduct disorder	0.00124	0.0215	CbGeAlD
Norepinephrine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00124	0.0014	CbGpPWpGaD
Norepinephrine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00123	0.0014	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00122	0.00138	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00121	0.00137	CbGpPWpGaD
Norepinephrine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00119	0.00135	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00119	0.00135	CbGpPWpGaD
Norepinephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00118	0.00134	CbGpPWpGaD
Norepinephrine—POU5F1—Developmental Biology—EP300—conduct disorder	0.00116	0.00132	CbGpPWpGaD
Norepinephrine—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.00115	0.00131	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00115	0.00131	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00114	0.0013	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00113	0.00128	CbGpPWpGaD
Norepinephrine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00112	0.00128	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00111	0.00126	CbGpPWpGaD
Norepinephrine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00109	0.00124	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00107	0.00121	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00107	0.00121	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.00103	0.00117	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—COMT—conduct disorder	0.00102	0.00116	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00102	0.00116	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR ligand binding—HTR2A—conduct disorder	0.00102	0.00116	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00102	0.00116	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.00102	0.00116	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00102	0.00115	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000984	0.00112	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000977	0.00111	CbGpPWpGaD
Norepinephrine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.00097	0.0011	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—COMT—conduct disorder	0.000954	0.00108	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.000947	0.00108	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—CGA—conduct disorder	0.000935	0.00106	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.000932	0.00106	CbGpPWpGaD
Norepinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000927	0.00105	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—DRD4—conduct disorder	0.000927	0.00105	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.000926	0.00105	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000918	0.00104	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.000918	0.00104	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000915	0.00104	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—CGA—conduct disorder	0.000915	0.00104	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—CGA—conduct disorder	0.00091	0.00103	CbGpPWpGaD
Norepinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000906	0.00103	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—DRD4—conduct disorder	0.000906	0.00103	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—COMT—conduct disorder	0.000892	0.00101	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—MAOA—conduct disorder	0.000885	0.00101	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—DRD4—conduct disorder	0.000882	0.001	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000871	0.00099	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000867	0.000986	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.000865	0.000983	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000858	0.000974	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.000858	0.000974	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000852	0.000968	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—CGA—conduct disorder	0.000849	0.000965	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CGA—conduct disorder	0.000845	0.00096	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000844	0.000959	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000844	0.000959	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.000841	0.000956	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—CGA—conduct disorder	0.000831	0.000944	CbGpPWpGaD
Norepinephrine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000809	0.000919	CbGpPWpGaD
Norepinephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000809	0.000919	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—DRD4—conduct disorder	0.000801	0.00091	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000794	0.000902	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000787	0.000894	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.000786	0.000893	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000785	0.000892	CbGpPWpGaD
Norepinephrine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000778	0.000884	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000778	0.000884	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000777	0.000882	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.000773	0.000879	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000756	0.000859	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00075	0.000852	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00075	0.000852	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000735	0.000835	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000723	0.000822	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000713	0.00081	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.000703	0.000799	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000697	0.000791	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.000697	0.000791	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000687	0.00078	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—WASF1—conduct disorder	0.000677	0.000769	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000667	0.000757	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.000663	0.000754	CbGpPWpGaD
Norepinephrine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000657	0.000747	CbGpPWpGaD
Norepinephrine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000652	0.000741	CbGpPWpGaD
Norepinephrine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000648	0.000736	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000642	0.00073	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.000638	0.000725	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	0.000605	0.000687	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.000599	0.000681	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000597	0.000678	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	0.000591	0.000672	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—HTR2A—conduct disorder	0.000576	0.000654	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.000575	0.000653	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CGA—conduct disorder	0.000571	0.000648	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.00056	0.000636	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000559	0.000635	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CGA—conduct disorder	0.000555	0.000631	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.000551	0.000626	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.00055	0.000625	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CGA—conduct disorder	0.000532	0.000604	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	0.000524	0.000595	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—HTR2A—conduct disorder	0.000523	0.000594	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.000522	0.000593	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.000519	0.000589	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	0.000512	0.000582	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000508	0.000577	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000503	0.000572	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CGA—conduct disorder	0.000502	0.00057	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.000497	0.000565	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CGA—conduct disorder	0.000491	0.000557	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000489	0.000556	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.000485	0.000551	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.000477	0.000542	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—DRD4—conduct disorder	0.000475	0.00054	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—DRD4—conduct disorder	0.000473	0.000538	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.000471	0.000535	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—DRD4—conduct disorder	0.000465	0.000528	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CGA—conduct disorder	0.000464	0.000527	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.000457	0.000519	CbGpPWpGaD
Norepinephrine—PAH—Disease—EP300—conduct disorder	0.000457	0.000519	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.000454	0.000516	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CGA—conduct disorder	0.000451	0.000512	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.000441	0.000501	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	0.00044	0.0005	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.00044	0.0005	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.000433	0.000492	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.000424	0.000481	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CGA—conduct disorder	0.000421	0.000479	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—COMT—conduct disorder	0.000411	0.000467	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—MAOA—conduct disorder	0.000408	0.000463	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.000406	0.000461	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—WASF1—conduct disorder	0.000402	0.000457	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—DRD4—conduct disorder	0.000399	0.000454	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.000398	0.000453	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.000394	0.000447	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—WASF1—conduct disorder	0.000393	0.000447	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.000385	0.000437	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—EP300—conduct disorder	0.000382	0.000434	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.000377	0.000428	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.000375	0.000426	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	0.000372	0.000423	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.000366	0.000416	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.000357	0.000406	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	0.000342	0.000388	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.00034	0.000387	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.000338	0.000385	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—WASF1—conduct disorder	0.000338	0.000384	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	0.000334	0.00038	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.000325	0.00037	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	0.000316	0.000359	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000311	0.000354	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	0.00031	0.000352	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—HTR2A—conduct disorder	0.000309	0.000351	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.000308	0.00035	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.000307	0.000349	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	0.000303	0.000345	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.000302	0.000343	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	0.000287	0.000326	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	0.000287	0.000326	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—EP300—conduct disorder	0.000284	0.000322	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.000283	0.000321	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—DRD4—conduct disorder	0.000281	0.000319	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.000278	0.000316	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.000276	0.000314	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—DRD4—conduct disorder	0.000275	0.000312	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—EP300—conduct disorder	0.000265	0.000301	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	0.000261	0.000296	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	0.00026	0.000295	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—COMT—conduct disorder	0.000258	0.000293	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.000257	0.000292	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.000256	0.000291	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—MAOA—conduct disorder	0.000256	0.000291	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.000251	0.000285	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—COMT—conduct disorder	0.000251	0.000285	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CGA—conduct disorder	0.000249	0.000283	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—MAOA—conduct disorder	0.000249	0.000283	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—COMT—conduct disorder	0.00024	0.000273	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—MAOA—conduct disorder	0.000238	0.000271	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—DRD4—conduct disorder	0.000236	0.000268	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.000233	0.000265	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.000227	0.000258	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—EP300—conduct disorder	0.000215	0.000245	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.000211	0.00024	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—COMT—conduct disorder	0.000204	0.000231	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—MAOA—conduct disorder	0.000202	0.00023	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.000201	0.000229	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HTR2A—conduct disorder	0.000183	0.000208	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.000182	0.000206	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HTR2A—conduct disorder	0.000179	0.000204	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—EP300—conduct disorder	0.000176	0.0002	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	0.00017	0.000193	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.000167	0.00019	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—EP300—conduct disorder	0.000164	0.000186	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HTR2A—conduct disorder	0.000154	0.000175	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000148	0.000168	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000138	0.000157	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—COMT—conduct disorder	0.000112	0.000128	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—MAOA—conduct disorder	0.000112	0.000127	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—EP300—conduct disorder	0.00011	0.000126	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000108	0.000123	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—EP300—conduct disorder	0.000107	0.000122	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000107	0.000121	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—EP300—conduct disorder	0.000103	0.000117	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EP300—conduct disorder	9.71e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EP300—conduct disorder	9.62e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EP300—conduct disorder	9.5e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EP300—conduct disorder	8.99e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EP300—conduct disorder	8.84e-05	0.0001	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—EP300—conduct disorder	8.73e-05	9.92e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EP300—conduct disorder	8.15e-05	9.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EP300—conduct disorder	7.86e-05	8.93e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EP300—conduct disorder	7.3e-05	8.29e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—EP300—conduct disorder	4.82e-05	5.47e-05	CbGpPWpGaD
